Christchurch-based medical device manufacturer Enztec says it is poised for growth after the closure of a $US27.5 million debt financing by parent company Orthopaedic Synergy, Inc (OSI).
The new funding is targeted at Enztec’s sister company – Massachusetts-based OMNILife Science, an
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Duncan Bridgeman
Mon, 05 May 2014
Mon, 05 May 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Major US funding kickstarts Kiwi surgical device company Enztec
37806